About

Providing straightforward information pertaining to drugs, drug use & drug policy. The Grey Pages promotes drug-related literacy and advocates a system of viable and tolerant drug policies. This is my personal collection of commentaries, essays, tid-bits, and other such writings on everything ranging from drug use, drug policy and drug-myths, to drug-science, addiction, human behavior, and the workings of the human brain. I started this blog with a particular focus on opioids, and over the past year have found my interest gravitate toward the intriguing, ever-changing world of designer intoxicants (i.e. "research chemicals" or "designer drugs").

Friday, June 22, 2012

Controlled Substance Analogues and the Law (For the Discerning RC Vendor or Enthusiast)





In order for any compound to be considered as a controlled substance analogue, the compound generally must meet the following criteria (criteria being A, B, and C; or alternately, A, B, and D)...

a) Intended for human consumption

b) Structure substantially similar to a class I or II drug

c) Produces a stimulant, depressant, or hallucinogenic effect substantially similar to (or stronger than) that produced by the drug in class I or II

OR

d) Is represented or intended to have a stimulant, depressant, or hallucinogenic effect similar to (or stronger than) that produced by the drug in class I or II

When, in a given situation, a substance meets the criteria as a controlled substance analogue, law enforcement can then prosecute the offender, and, in that specific instance, treat the analogue as a class I controlled substance.

What Can Not Be Considered a CSA?


Any compound not intended for human consumption (unless/until a takes effect to address that particular substance)

An already controlled substance (obviously)

A compound with an approved NDA (new drug application) filed with the FDA

Any substance exempted for investigational use (and only by a person who has been specifically authorized)

Further Reading: 

Contents of the Federal Analogue Act (Erowid)

No comments:

Post a Comment